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Short- and Long-Term Effectiveness
of Coral Disease Treatments
Karen L. Neely1* , Colin P. Shea2, Kevin A. Macaulay1, Emily K. Hower1 and
Michelle A. Dobler1
1 Halmos College of Natural Sciences and Oceanography, Nova Southeastern University, Fort Lauderdale, FL, United States,
2 Fish and Wildlife Research Institute, Florida Fish and Wildlife Conservation Commission, St. Petersburg, FL, United States
Since 2014, stony coral tissue loss disease (SCTLD) has led to large-scale mortality
of over 20 coral species throughout the Florida Reef Tract. In 2019, in-water disease
intervention strategies were implemented to treat affected corals. Two treatment
strategies were employed: (1) topical application of an amoxicillin paste directly to
disease margins, and (2) application of a chlorinated epoxy to disease margins as
well as an adjacent “disease break” trench. Effectiveness of treatments on 2,379
lesions from 725 corals representing five species was evaluated using mixed effects
logistic regression models which demonstrated substantially greater effectiveness of
amoxicillin compared to chlorine-treated lesions across all species up to 3 months
post-treatment. As a result of the failed chlorinated epoxy treatments, any new lesions
that appeared during subsequent monitoring events were treated with amoxicillin paste,
and all corals were monitored and treated as needed approximately every 2 months
for up to 24 months. The health status of 1664 amoxicillin-treated corals during each
monitoring event was used to model the probability of a coral being uninfected over
time. Models included species and geographic regions as variables. The appearance
of new lesions (reinfection rates) varied by species, and offshore sites showed greater
reinfection rates than inshore sites; however, all sites and species exhibited a decreased
probability of reinfection with time since initial treatment. We conclude that topical
amoxicillin treatments are highly effective at halting SCTLD lesions and that through
initial and follow-up treatments as needed, colonies and reef sites will progress toward
a lower prevalence of SCTLD.
Keywords: stony coral tissue loss disease, disease treatment, antibiotics, chlorinated epoxy, mixed effects
logistic regression model
INTRODUCTION
Coral diseases are found on reefs throughout the world and are one of the most rapid and prevalent
sources of coral mortality, even among the myriad stressors that are driving the decline of reefs.
The first report of coral disease was published in Squires (1965). Since then, diseases have been
documented in over 100 coral species and over 50 different nations (Green and Bruckner, 2000;
Bruckner, 2016). Even though disease is traditionally present in ecosystems, elevated prevalence
and virulence has resulted in elevated “background” rates as well as increasingly common outbreaks
that can affect coral cover and species diversity (Cróquer et al., 2005). Coral disease has led
to substantial changes in reef communities, from localized declines in various species (Cróquer
et al., 2005) to the widespread loss of over 90% of acroporid corals throughout the Caribbean
(Aronson and Precht, 2001).
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Many coral diseases have correlations with environmental
stressors. For example, some diseases have peak prevalence
during and following periods of thermal stress; these include
white pox (Patterson et al., 2002), yellow band (Cervino et al.,
2004; Cróquer and Weil, 2009), white plague (Cróquer and
Weil, 2009), black band disease (Boyett et al., 2007; Lewis et al.,
2017), and potentially white band disease (Randall and van
Woesik, 2015). Water quality is also likely to play a role in
overall disease prevalence; white pox has been tied to human
fecal matter (Patterson et al., 2002), elevated nutrients have been
shown to increase the prevalence and severity of dark spot disease
(Thurber et al., 2014), and white plague outbreaks in the lower
Florida Keys have correlated with periods of enriched nitrogen
loading (Lapointe et al., 2019). Projections indicate that disease-
conducive conditions are increasing rapidly and that disease is
likely to be just as significant a driver of coral decline as bleaching
(Maynard et al., 2015).
Despite this, successful identification of coral disease
pathogens continues to be challenging (Richardson, 1998),
and potential treatment options are rare. Some coral disease
treatments have been conducted for experimental and diagnostic
purposes. These have ranged across seven different coral
diseases with varying levels of success (Figure 1). Treatment
types can be classified as mechanical (e.g., removal of diseased
tissue, shading, smothering, and creating trenches), chemical
(antiseptics or antibiotics, sometimes included within a
mechanical treatment), or biological (phage therapy). Most
treatments to date have involved mechanical methods such
as separating diseased tissue from healthy tissue or in some
way covering the disease margin (Hudson, 2000; Muller
and Van Woesik, 2009; Dalton et al., 2010; Williams, 2013;
Miller et al., 2014; Aeby et al., 2015; Randall et al., 2018).
Results using these mechanical treatments have ranged from
ineffective to relatively successful. The use of antibiotics is
common in treating human and animal diseases (including
heavy prophylactic use in agriculture), but their usage, even
experimentally, for coral diseases has been limited. Two
treatments have been used diagnostically to determine the
presence of a bacterial component in white band disease
(Kline and Vollmer, 2011; Sweet et al., 2014), and a third was
unsuccessfully used as a conservation effort for corals with
black band disease (Gil-Agudelo et al., 2004). Biological control
of bacterial pathogens in corals has also been tested using
phage therapy, in which a viral phage is used to target the
causative agent. On Red Sea corals affected with white plague,
this has been shown to slow tissue loss (Atad et al., 2012),
prevent transmission (Efrony et al., 2009), and halt disease
when applied prophylactically or within early stages of infection
(Efrony et al., 2007, 2009).
While not all historical coral disease treatments have resulted
in disease cessation, the success of some demonstrates that
field treatment of coral diseases, at least on targeted colonies,
is possible. Though disease outbreaks are heavily managed for
humans and agricultural biomass (both plant and animal),
disease outbreaks within wildlife populations are generally
left untouched. Though guidelines have been suggested for
management at different stages of wildlife disease outbreaks
(Langwig et al., 2015), the relatively few instances of active
management of an outbreak traditionally occur in cases
in which:
1. Human or agricultural health is threatened by the
wildlife outbreak. Examples include baiting foxes with
an antihelmintic to reduce risk of human infection
(Tackmann et al., 2001), releasing sterile flies to control
an outbreak of screwworms in Florida key deer to prevent
transmission to animal stock (Skoda et al., 2018), and
widespread wildlife vaccinations in Europe and North
America to reduce and/or eliminate terrestrial rabies
(Sterner et al., 2009; Mähl et al., 2014).
2. Ecosystem services (including harvest of a resource) are
threatened. Examples of various treatment efforts include
culling, chemical application, and biological control for
pine beetles in American forests (Fettig et al., 2013).
3. Rare and highly managed species are at risk. Examples
include California condors vaccinated against West Nile
virus (Chang et al., 2007), Ethiopian and red wolves
vaccinated against rabies (Harrenstien et al., 1997; Haydon
et al., 2006), black-footed ferrets vaccinated against sylvatic
plague (Abbott et al., 2012), arctic foxes treated with
antiparasitic drugs for mange (Goltsman et al., 1996), and
environmental disinfection and antifungal treatments on
Mallorcan midwife toads (Bosch et al., 2015).
Stony coral tissue loss disease (SCTLD) has emerged as a major
threat to Caribbean coral reefs. First documented near Miami,
Florida in 2014 (Precht et al., 2016), it spread over the next 5
years throughout the majority of the Florida Reef Tract (Muller
et al., 2020; Neely et al., 2021). Beginning in 2018, observations
of SCTLD were documented in Mexico (Alvarez-Filip et al.,
2019) and subsequently throughout other regions of the northern
Caribbean (Weil et al., 2019). Work to identify the pathogen
is ongoing, but transmission experiments show that infection
is possible through physical contact as well as through sterile
seawater (Aeby et al., 2019). Mortality rates are high, resulting
in extensive loss of colonies (Precht et al., 2016) and localized
near-extinction of highly susceptible species (Neely et al., 2021).
Coral cover, species diversity, and colony density have all declined
significantly in affected areas (Walton et al., 2018; Alvarez-Filip
et al., 2019; Heres et al., 2021). Given the threat presented by
SCTLD to Caribbean reefs, unprecedented actions have been
taken to understand and mitigate this disease. In Florida, these
include interagency steering committees, coral rescue activities,
and scaled-up propagation and restoration plans. The response
has also included novel and large-scale efforts to save infected
colonies in situ.
By utilizing and modifying methodologies from the literature
and expanding aquarium practices of antibiotic dosing to develop
a topical application (Miller et al., 2018), two disease intervention
procedures were implemented on Florida Keys reefs in an attempt
to arrest active SCTLD lesions. We compared the effectiveness of
chlorinated epoxy treatments and antibiotic paste treatments on
halting disease lesions, and assessed the long-term infection rates
of treated colonies.
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FIGURE 1 | Effectiveness of treatments on corals afflicted with seven diseases, as reviewed from the literature. Effectiveness is color coded as follows: green
(effective), yellow (mixed results), red (ineffective). References: 1. Miller et al. (2014); 2. Dalton et al. (2010); 3. Williams (2013); 4. Randall et al. (2018); 5. Muller and
Van Woesik (2009); 6. Hudson (2000); 7. Aeby et al. (2015); 8. Sweet et al. (2014); 9. Kline and Vollmer (2011); 10. Gil-Agudelo et al. (2004); 11. Efrony et al. (2007);
12. Efrony et al. (2009); 13. Atad et al. (2012).
FIGURE 2 | Location of coral disease treatment sites within the Florida Keys National Marine Sanctuary (FKNMS). Regions are defined as lower, middle, and upper
Keys. Colors represent inshore (orange) and offshore (purple) sites.
MATERIALS AND METHODS
Sites and Treatments
Ten sites throughout the Florida Keys National Marine Sanctuary
(FKNMS) were selected for treatment (Figure 2). Sites ranged
in depth from 4 to 12 m. Most were located in no-take marine
reserves; exceptions were Marker 48 as well as approximately
half of the corals at Cheeca Rocks, which straddled the boundary
of a no-take area. Initial treatments occurred between January
2019 and April 2020 (Table 1). As SCTLD spread through the
FKNMS in a north to south gradient as well as an offshore to
inshore gradient, reefs were not all experiencing the same level
of disease during initial treatments; for example, offshore sites in
the upper Keys were first treated several years after the arrival
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TABLE 1 | Dates and number of corals (N) treated with amoxicillin paste and chlorinated epoxy treatments during the initial visits to each site.
Site Treatment dates N amoxicillin N chlorine # diseased corals per 100 m2
Upper Keys January 2019 23 14 0.04
Sombrero February 2019 61 46 0.35
Looe Key February to April 2019 329 303 1.03
Sand Key October 2019 23 0 N/A
Cheeca Rocks April 2020 241 0 1.03
Marker 48 April 2020 120 0 3.04
Newfound Harbor April 2019 160 0 1.75
of SCTLD while some inshore and southern sites were treated
within a year of first appearance. Disease status during treatment
of offshore sites in the upper Keys was similar, and so corals from
Carysfort South, Grecian, Key Largo Dry Rocks, and Molasses
are clumped for analysis. No pre-treatment prevalence data were
taken, but considering that most to all of the diseased corals
were treated, we used a GIS to estimate the area searched at
each site and divided by the number of corals treated in order
to estimate the density of diseased corals in an area (Table 1). Not
all corals at Sand Key were treated and so no estimate is provided
for that location.
Habitat characteristics surrounding each treatment site were
analyzed in a GIS using the Unified Florida Coral Reef Tract
Map v1.2 (Florida Fish and Wildlife Research Institute, 2014).
For each treatment site, a 4km buffer was overlaid on the
habitat map’s Level 1 classification scheme to determine the
percentages of the surrounding radial area that were comprised
of reef, pavement/unconsolidated substrate, seagrass, land, and
offshore habitat.
At each treatment site, divers searched the reef to identify
corals for treatment using the “priority coral guiding principles”
outlined in the Coral Disease Intervention Action Plan (Neely,
2018). Treated corals were generally large, had a large amount
of remaining live tissue, and were not overwhelmed with
SCTLD lesions. At sites treated between January and April 2019,
each coral was haphazardly assigned one of two treatments:
chlorinated epoxy or amoxicillin paste. As a result of high failure
rates on chlorine-treated corals, all sites treated after April 2019
used only amoxicillin paste. In total, 1320 corals were treated
during initial site visits and an additional 865 were treated
during subsequent monitoring events through October 2020
(total of 2185).
Because many corals and species had already perished at long-
diseased sites, the abundance and diversity of corals that could
be treated at each site varied (Figure 3). The density of treatable
corals was notably lower at the Upper Keys and Sombrero sites
(0.04 and 0.35 corals per m2) compared to offshore Looe Key
and the three inshore sites (1.03 to 3.04 corals per m2). Across
all sites, the three most commonly treated species were Orbicella
faveolata (37%), Montastraea cavernosa (21%), and Colpophyllia
natans (16%). O. faveolata and M. cavernosa dominated offshore
reef treatments, while inshore reef treatments were dominated
by the brain corals C. natans and Pseudodiploria clivosa (at
the Newfound Harbor site). The average maximum diameter of
treated colonies was 115 cm (± 84 SD).
Each selected coral was tagged and mapped for future
identification. Corals were identified to species, and 1” masonry
nails were placed at each active lesion. Photographs of the colony
and each lesion were taken before and after treatments.
Chlorinated epoxy was mixed following methodology
formerly used on black band disease on Pacific reefs (Aeby
et al., 2015). Before entering the water, chlorine powder
(78% calcium hypochlorite) was folded by hand into Part
A of SplashZone two-part epoxy in a 3:10 by volume ratio.
Once stationed at a selected coral, divers would hand-mix the
chlorinated Part A with the non-chlorinated Part B and apply
the mixture directly to all active disease margins. Additionally,
an underwater angle-grinder was used to create a trenched
disease break approximately 5 cm from each active disease
lesion. Disease breaks were approximately 1 cm wide and
1 cm deep. Each disease break was also packed with the
chlorinated epoxy mixture.
The amoxicillin paste was created by hand-mixing amoxicillin
trihydrate (98.1% purity, sourced from Phytotechnology
Laboratories) into a specially formulated silicone-based paste
termed Base2b. The proprietary base (CoreRx/Ocean Alchemists)
includes polymers to mimic coral mucus consistency and releases
amoxicillin over a 3-day time period. The Base2b and amoxicillin
were hand-mixed no more than 36 h before application to the
corals and packed into 60cc catheter-tip syringes. At the corals
selected for treatment, divers would syringe the product onto
active disease lesions and then press it into the bare skeleton
for adhesion. The product made a band approximately 1 cm in
width, with about half overlaying live tissue and the other half
anchoring to the skeleton.
Colonies were revisited over the course of up to 710 days for
monitoring and treatment of new lesions as needed. The goal for
monitoring was for each coral to be revisited at 1 month, and
then every 2 months thereafter. Actual monitoring varied slightly,
particularly at Looe Key which was initially split into two regions
for monitoring every other month. During each monitoring
event, photographs were taken of the whole colony and of each
current and previously treated disease lesion. Photographs from
each monitoring event were used to assess whether the treatments
had been effective (defined as the active lesion halting at the
treatment line) or ineffective (defined as the lesion continuing
past the treatment line across the colony) (Figure 4). For lesions
with chlorinated epoxy applications, ineffective treatments were
defined as those that had passed both the margin treatment and
the disease break.
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FIGURE 3 | Species composition of corals treated at FKNMS sites. Top numbers indicate the total number of treated corals at each site.
Corals that had active disease lesions during subsequent
monitoring events received additional treatments on new lesions
as needed. However, there were some instances where this did
not occur. In the upper Keys, Sombrero, and some parts of Looe
Key, colonies monitored 1 month after the initial treatment did
not receive additional treatments at that time. Additionally, a
small number of corals across all sites displayed active disease
during monitoring, but no longer qualified as priority corals and
were not treated again. By April 2019, it was clear that chlorine
treatments were largely unsuccessful, and follow-up treatments
were done with amoxicillin paste regardless of whether the
coral was initially treated with amoxicillin or chlorine. The
exception was 38 corals at Looe Key that were initially treated
with chlorinated epoxy and were re-treated with chlorinated
epoxy on active disease areas during the 2-month monitoring;
these were all treated during subsequent monitoring events with
amoxicillin if needed. During each monitoring event, every coral
was categorized as either (1) dead, (2) active lesions – untreated,
(3) treated, or (4) no active disease (NAD).
Analyses
Lesion-Level Effectiveness
The effectiveness of amoxicillin and chlorine treatments at
halting disease lesion progression for 3 months post-treatment
was evaluated using a mixed effects logistic regression analysis.
The binary response variable represented the effectiveness (1)
or ineffectiveness (0) of treatment on 2,379 individual lesions
present on 725 colonies from five species (Colpophyllia natans,
Pseudodiploria strigosa, Diploria labyrinthiformis, Montastraea
cavernosa, and Orbicella faveolata). Treated lesions were
monitored periodically (Supplementary Figure 1A) during
the initial 140-day time frame in the upper Keys (Carysfort
South, Key Largo Dry Rocks, Grecian Rocks), middle Keys
(Sombrero Reef), and lower Keys (Looe Key). If a lesion required
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FIGURE 4 | Time series photos showing effective amoxicillin treatments and ineffective chlorinated treatments on two coral species: Colpophyllia natans (CNAT) and
Montastraea cavernosa (MCAV). Disease lesions were defined as ineffective only once they had crossed both the margin and disease break chlorinated epoxy
treatments.
retreatment, it was considered ineffective for that and future
monitoring events.
We fit a candidate set of eight logistic regression models,
each of which included a different combination of the predictors
and two-way interaction terms (treatment type; region; species;
number of days since treatment; number of days since treatment
× treatment type, region × treatment type, and species ×
treatment type). To account for non-independence of repeated
observations of lesions on the same colonies, we included a
random intercept associated with unique corals (Gellman and
Hill, 2007). We ranked the plausibility of each candidate model
using Akaike’s Information Criterion [AIC; Akaike (1973)] with
a small-sample bias adjustment [AICc; Hurvich and Tsai (1989)].
To quantify the relative support of each candidate model, we
calculated Akaike weights (w) that range from zero to one,
with the best-approximating model having the highest weight
(Burnham and Anderson, 2002). The ratio of Akaike weights
for two candidate models can be used to assess the degree of
evidence for one model over another; for example, a model
with an Akaike weight of 0.9 is 10 times more likely to be
the best-approximating model compared to a model with an
Akaike weight of 0.09. We based all inferences on the best-
approximating model i.e., the model with the lowest AICc
score. Following model-fitting and model selection, we assessed
goodness-of-fit for each model in the candidate set using
a residual-based, simulation approach implemented in the R
package “DHARMa” (Hartig, 2019). Additionally, we assessed
the performance for each model by calculating an area under
the receiving operator characteristic curve (AUC) statistic. AUC
values > 0.5 indicate that a model predicts a categorical outcome,
on average, better than random chance alone. All statistical
analyses were conducted in R v.4.0.3 (R Development Core Team,
2013) using the packages “glmmTMB” [model fitting: logistic
regression with logit link function; Brooks et al. (2017)] and
“ROCR” [predictive performance; Sing et al. (2005)].
Following model fitting, we implemented post hoc contrasts
(Tukey-adjusted pairwise comparisons with a 95% familywise
confidence level) in R using the “emmeans” package (Lenth,
2018) to provide a more detailed assessment of differences in
treatment effectiveness among species and regions.
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Colony Health Status
The health status of amoxicillin-treated corals was evaluated
using mixed effects logistic regression to estimate the probability
of a coral within the treatment regime being observed with
no active disease (NAD) during monitoring. A total of
1,664 coral colonies representing eight species (C. natans,
D. labyrinthiformis, D. stokesii, M. cavernosa, O. annularis,
O. faveolata, P. strigosa, and S. siderea) were visited a total of
9956 times ranging from 8 to 710 days after initial treatment
(Supplementary Figure 1B). The binary response variable
represented the absence (1) or presence (0) of disease. Here,
the absence of disease was defined as instances where a colony
previously afflicted by SCTLD no longer exhibited any evidence
of active disease. Any colonies with active lesions or mortality
were considered diseased. We fit a candidate set of eight mixed
effects logistic regression models, each of which included a
different combination of the predictor variables (region; habitat;
species; number of days since treatment; and all two-way
interactions between region, habitat, and species). As with
the 3-month lesion treatment analysis, we accounted for non-
independence of repeated observations on the same colonies by
including a random intercept associated with unique corals. We
again ranked the plausibility of each candidate model using AICc
and Akaike weights. Lastly, we based all inferences on the model
with the lowest AICc score and assessed goodness of fit and
predictive performance as described above for the 3-month lesion
treatment effectiveness model.
Following model fitting, post hoc contrasts (Tukey-adjusted
pairwise comparisons with a 95% familywise confidence level)
were again implemented in R using the “emmeans” package to
provide a more detailed assessment of differences in long-term
disease status among species, regions, and habitats.
RESULTS
Lesion-Level Effectiveness
The best-approximating mixed effects logistic regression model
assessing the probability of successful lesion treatment included
number of days since treatment, treatment type, region,
species, number of days since treatment × treatment type,
region × treatment type, and species × treatment type.
Akaike weights indicated that this model was 10.1 times
(0.91/0.09) more plausible than the next-best approximating
model, which was similar but excluded the region × treatment
type interaction term. There was no support for the remaining six
candidate models (Supplementary Table 1). The goodness of fit
assessments based on scaled residuals indicated that all candidate
logistic regression models provided an adequate fit to the data.
Lastly, the AUC statistics for the eight candidate models ranged
from 0.96 to 0.97, indicating they were all capable of predicting
the observed data well.
Across all species and regions, the probability of amoxicillin
treatment effectiveness was high. At 109 days, predicted
effectiveness exceeded 95% among all tested species at Looe
and the upper Keys. Effectiveness was slightly lower for
D. labyrinthiformis and O. faveolata at Sombrero, but still
exceeded 75% (Figure 5). Across regions, amoxicillin treatments
responded similarly, with the exception of corals at Sombrero,
which did not respond to treatment as effectively as corals
at Looe (Tables 2, 3). This regional pairwise comparison is
significant (p < 0.0001), but the magnitude of differences was
minor as effectiveness was still high at both sites. Based on the
best approximating model across all regions and times within
the 3-month analyses, all five species responded equally well to
amoxicillin (Table 4).
In contrast to amoxicillin treatments, chlorinated epoxy
treatments were ineffective (Figure 5). This chlorinate epoxy
effectiveness was equally poor across all regions, and was
significantly less effective than amoxicillin treatments across all
regions (p < 0.001) (Tables 2, 3). Among species, the brain
corals C. natans, D. labyrinthiformis, and P. strigosa had lower
effectiveness rates than the boulder corals M. cavernosa and
O. faveolata (Tables 2, 4). However, these summaries are across
all times after treatment; while M. cavernosa and O. faveolata
treatments did not fail as early as those of the brain corals, their
rate of effectiveness 3 months after treatment was less than 20%.
Colony Health Status
To assess the probability of a coral having no active disease
(NAD) at up to 24 months after initial treatment and necessary
touchups, eight mixed effects logistic regression models were
considered for goodness of fit. The best fit model contained
the following parameters: number of days since treatment,
habitat (inshore or offshore), region (upper Keys, middle Keys,
or lower Keys), species, a habitat × species interaction term,
and a region × species interaction term. Akaike weights (w)
indicated that this model was 6.9, 8.6, and 11.5 times more
plausible than the second, third, and fourth best-approximating
models, respectively, and there was very little support for the
remaining four candidate models (Supplementary Table 2).
The goodness of fit assessments based on scaled residuals
indicated that all candidate logistic regression models provided
an adequate fit to the data. Lastly, the AUC statistics
for the eight candidate models ranged from 0.86 to 0.87,
indicating they were capable of predicting the observed data
reasonably well.
Parameter estimates from the best-approximating model
indicated a positive relationship between the date after initial
treatment and the probability of NAD (Table 5 and Figure 6).
The most pronounced variable affecting this probability was
habitat (inshore vs. offshore). After 24 months, the proportion
of colonies with NAD exceeded 95% for most species at
inshore sites. In contrast, several species had NAD rates
of less than 80% at offshore sites. Of the eight compared
species (C. natans, D. labyrinthiformis, D. stokesii, M. cavernosa,
O. annularis, O. faveolata, P. strigosa, and S. siderea), all but
D. stokesii and O. annularis had significantly higher NAD values
at inshore sites than offshore sites (Table 6). Some species-
specific variations in NAD rates were apparent within different
geographies, with more differences occurring at offshore sites
(Table 7). Orbicella faveolata performed more poorly (lower
NAD values) than C. natans (offshore middle Keys, offshore
upper Keys, inshore upper Keys), D. labyrinthiformis (offshore
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FIGURE 5 | Mean predicted probability (solid lines) of effective lesion treatment for three months after application. Amoxicillin and chlorinated epoxy effectiveness
levels are shown for five species across three sites. Shaded areas represent 95% confidence intervals.
lower Keys), P. strigosa (inshore upper Keys), and M. cavernosa
(offshore middle Keys). S. siderea also performed more poorly
than P. strigosa (offshore lower Keys) and M. cavernosa
(offshore lower Keys and offshore upper Keys). Colpophyllia
natans performed more poorly than M. cavernosa in the
offshore middle Keys.
DISCUSSION
Clear differences between treatment types were apparent in
assessing effectiveness on SCTLD lesions. Chlorinated epoxy
treatments on SCTLD lesions were highly ineffective, with
corals of all species at all sites exhibiting high rates of failure
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TABLE 2 | Parameter estimates affecting the probability of halted disease progression up to 3 months after treatment.
Parameter Estimate SE LCL UCL p-value
Fixed effects
Intercept 6.458 0.960 4.576 8.340 <0.0001
Treatment Chlorine −7.814 1.345 −10.450 −5.178 <0.0001
Time Days −0.013 0.005 −0.024 −0.003 0.011
Region Sombrero −2.478 0.494 −3.446 −1.509 <0.0001
Upper Keys (UK) −1.049 0.675 −2.371 0.273 0.120
Species D. labyrinthiformis (DLAB) −1.521 1.253 −3.977 0.936 0.225
M. cavernosa (MCAV) −0.007 0.907 −1.785 1.771 0.994
O. faveolata (OFAV) −0.634 0.873 −2.345 1.076 0.467
P. strigosa (PSTR) 1.510 1.683 −1.788 4.808 0.370
Treatment × Time Chlorine × Days −0.046 0.008 −0.061 −0.031 <0.0001
Treatment × Region Chlorine × Sombrero 1.698 0.575 0.570 2.826 0.003
Chlorine × UK 0.842 1.042 −1.200 2.884 0.419
Treatment × Species Chlorine × DLAB 3.009 1.889 −0.693 6.711 0.111
Chlorine × MCAV 5.875 1.321 3.286 8.464 <0.0001
Chlorine × OFAV 7.444 1.353 4.793 10.095 <0.0001
Chlorine × PSTR 0.139 2.052 −3.883 4.161 0.946
Random effects
Intercept (Coral ID) 2.813
Parameter estimates, standard errors (SE), lower and upper 95% confidence limits (LCL and UCL), and p-values are from the best-approximating mixed effects logistic
regression model. All estimates are on the log-odds scale, and random effects are reported as standard deviations. The default parameters for comparison were:
Treatment – Amoxicillin, Days – 0, Region – Looe Key, Species – Colpophyllia natans (CNAT).
TABLE 3 | Significant differences (p-values) in modeled treatment effectiveness among treatment types (amoxicillin and chlorine) and regions (Looe: lower Keys,
Sombrero: middle Keys, and UK: upper Keys).
Amoxicillin Chlorine
Looe Sombrero UK Looe Sombrero UK
Amoxicillin Looe <0.0001 0.629 <0.0001 <0.0001 <0.0001
Sombrero <0.0001 0.421 <0.0001 <0.0001 <0.0001
UK 0.629 0.421 <0.0001 <0.0001 <0.0001
Chlorine Looe <0.0001 <0.0001 <0.0001 0.626 1.000
Sombrero <0.0001 <0.0001 <0.0001 0.626 0.990
UK <0.0001 <0.0001 <0.0001 1.000 0.990
Tests are Tukey-adjusted pairwise comparisons. All amoxicillin treatments were more successful than all pairwise chlorinated treatments. Chlorinated treatments all
performed equally poorly. Among amoxicillin treatments, Looe treatments were slightly but significantly more effective than those at Sombrero.
within the first 3 months. Effectiveness rates decreased with
time and varied by species, largely based on the species-
specific rate of lesion progression. On brain corals (P. strigosa,
C. natans, and D. labyrinthiformis), lesions progressed quickly
across the colonies, and by the first monitoring period, lesions
had usually progressed past both the margin treatment and the
disease break treatment, constituting a fully ineffective lesion
treatment. In contrast, on species with slower lesion progression
(O. faveolata and M. cavernosa) lesions had generally only
crossed the chlorinated disease margin treatment 1 month after
treatment; during later observations, the continually progressing
lesion had also crossed the disease break and was scored as
ineffective (Figure 4). Thus, the seemingly high rates of chlorine
treatment effectiveness on some species immediately following
treatment were not representative of treatments that halted
disease progression.
In contrast, amoxicillin treatments were highly effective,
quickly halting lesion progression on all species at all sites.
There were no differences in amoxicillin effectiveness on
treated lesions among species, indicating this methodology is
suitable and effective for the suite of SCTLD-affected species.
Though sample sizes for other coral species were too small
for inclusion in the logistic models, a total of 16 species have
been treated with the amoxicillin paste with similar success
rates. In comparing treatments with placebos, Neely et al. (2020)
confirmed amoxicillin rather than the application paste as the
active ingredient. As a result of these comparative studies,
chlorinated epoxy treatments were discontinued in Florida and
are not recommended for SCTLD-affected corals.
Tracking of long-term colony health confirmed that while
SCTLD lesions can be halted by amoxicillin treatments,
additional distinct lesions may subsequently appear on treated
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TABLE 4 | Significant differences (p-values) in modeled treatment effectiveness
among species under two different treatment types (amoxicillin and
chlorinated epoxy).
Amoxicillin treatments
CNAT DLAB PSTR MCAV OFAV
CNAT 0.744 0.898 1.000 0.950
DLAB 0.744 0.411 0.572 0.895
PSTR 0.898 0.411 0.854 0.603
MCAV 1.000 0.572 0.854 0.651
OFAV 0.950 0.895 0.603 0.651
Chlorinated epoxy treatments
CNAT DLAB PSTR MCAV OFAV
CNAT 0.838 0.639 <0.0001 <0.0001
DLAB 0.838 1.000 0.007 <0.001
PSTR 0.639 1.000 <0.001 <0.001
MCAV <0.0001 0.007 <0.001 0.227
OFAV <0.0001 <0.001 <0.001 0.227
Tests are Tukey-adjusted pairwise comparisons. There was no difference
among modeled success rates of amoxicillin treatments among species. Among
chlorinated epoxy treatments, Montastraea cavernosa and Orbicella faveolata
performed significantly better, but these results were summed over the 3-month
period and do not reflect results toward the end of that time period.
colonies. These lesions may be the result of systemic infection
or of reinfection from the environment. Much of the histological
and microbiome studies on SCTLD-affected corals remains
inconclusive as to whether SCTLD is systemic within a colony or
localized to the visible infection site. For example, gastrodermal
necrosis was found in 87% of visually diseased histological
samples as well as in 11% of apparently healthy areas of
tissue (Landsberg et al., 2020). And microbial communities on
apparently healthy tissue of affected colonies are sometimes
similar to those of unaffected colonies while other times more
similar to those at active lesions (Meyer et al., 2019; Rosales et al.,
2020; Thome et al., 2021). It has also been suggested that the
bacteria seen in microbiome studies are purely opportunistic,
capitalizing on other underlying health issues (Landsberg
et al., 2020). Whether new lesions are caused by independent
infection events or an underlying systemic condition has
important implications for long-term colony health and disease
management and certainly warrants future research.
Though new lesions could appear on previously treated
colonies, corals that received regular monitoring and lesion
touch-ups as needed progressively exhibited improved health (no
active lesions) over time. Possible mechanisms by which initial
and follow-up treatments as necessary could contribute to this
include:
1. Reducing the potentially systemic infection within
colonies, sometimes through multiple treatments,
resulting in decreased lesions development.
2. Reducing opportunistic harmful bacteria on a colony that
lead to rapid tissue loss, even if bacteria are not the
underlying cause of SCTLD.
3. Reducing the pathogen load of either disease-inducing or
opportunistic bacteria across the site as a whole through
multiple visitations and treatments, thus minimizing new
infections and lesions across all colonies.
The mechanism behind treatments leading to healthy colonies
is recommended as a topic for further research. In particular,
why some colonies do not show signs of SCTLD after a single
treatment while others continually exhibit new lesions is relevant
for questions of resilience and assisted reproduction. The impact
of treatments in reducing pathogen load and protecting the
surrounding non-infected colonies is also unknown and of
importance for effective SCTLD management.
For the purposes of terminology, we will refer to the
appearance of a new distinct lesion as a “reinfection,” though as
acknowledged above, alternate hypotheses suggest it may be a
result of systemic influences. The colony-level assessment models
show that the probability of reinfection (i.e., the inverse of the
probability of NAD) was not the same across all species. In
particular, O. faveolata and S. siderea were more likely than
other species to develop new lesions, particularly at offshore sites.
One possible explanation is that the particularly large size of the
O. faveolata colonies in relation to the other species provides
more surface area for new infection events. However, S. siderea
were comparable in size to other species, and also showed high
reinfection rates. We suggest that somehow these species are
physiologically more inclined toward reinfection. Considering
that O. faveolata is the most important reef builder remaining
on offshore Florida Keys reefs, and that S. siderea is the most
abundant species on Florida Keys reefs, determining why these
species do not perform as well as others following treatment is an
important research question.
Almost all treated species showed significantly better long-
term response rates at inshore reefs compared to offshore
reefs. We here propose four hypotheses for this, which are
recommended avenues of future research.
1. Bleaching at inshore reefs halted disease progression
annually. During the summers of 2019 and 2020, severe
paling and bleaching was seen on most individuals
at the inshore sites, but not on the offshore sites.
This paling/bleaching coincided with an almost complete
cessation of active disease. This correlation between
zooxanthellae loss and SCTLD lesions has also been
observed at other Florida sites (Sharp et al., 2020) and
in the United States Virgin Islands (Meiling et al., 2020).
These inshore bleaching events may have reduced or
eliminated the reef pathogen load, either superseding or
working in collaboration with our intervention efforts,
to rapidly diminish the possibility of subsequent new
infections. Meiling et al. (2020) suggest that disease
treatment efforts could be made more efficient by working
during and immediately following such bleaching events;
we suggest that year-round intervention even in areas likely
to experience regular bleaching is important in order to
keep colonies alive through times when disease is more
likely to be abundant.
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TABLE 5 | Parameter estimates affecting the probability of a colony within the monitoring and touch-up regime being without disease up to 24 months after
initial treatment.
Parameter Estimate SE LCL UCL p-value
Fixed effects
Intercept 1.143 0.210 0.732 1.554 <0.0001
Days 0.003 0.000 0.002 0.004 <0.0001
Habitat Offshore −1.423 0.286 −1.983 −0.863 <0.0001
Species D. labyrinthiformis (DLAB) 0.295 0.462 −0.609 1.200 0.52
D. stokesii (DSTO) −0.372 0.285 −0.932 0.187 0.19
M. cavernosa (MCAV) −0.066 0.307 −0.667 0.535 0.83
O. annularis (OANN) 0.149 0.960 −1.734 2.031 0.88
O. faveolata (OFAV) −0.114 0.289 −0.680 0.451 0.69
P. strigosa (PSTR) 1.012 0.462 0.106 1.918 0.03
S. siderea (SSID) 0.107 0.308 −0.496 0.710 0.73
Region Middle Keys (MK) −0.713 0.270 −1.243 −0.182 0.01
Upper Keys (UK) 0.492 0.265 −0.028 1.011 0.06
Habitat × Species Offshore × DLAB 0.068 0.538 −0.986 1.123 0.90
Offshore × DSTO −0.530 1.142 −2.767 1.708 0.64
Offshore × MCAV 0.796 0.368 0.076 1.517 0.03
Offshore × OANN −0.019 0.938 −1.858 1.820 0.98
Offshore × OFAV −0.365 0.344 −1.039 0.310 0.29
Offshore × PSTR −0.180 0.542 −1.243 0.883 0.74
Offshore × SSID −0.832 0.522 −1.856 0.192 0.11
Region × Species MK × DLAB −0.529 0.761 −2.021 0.963 0.49
MK × DSTO 0.841 0.963 −1.047 2.728 0.38
MK × MCAV 0.664 0.357 −0.036 1.364 0.06
MK × OANN 0.403 0.850 −1.262 2.069 0.63
MK × OFAV 0.728 0.334 0.074 1.382 0.03
MK × PSTR −1.499 0.752 −2.972 −0.025 0.05
MK × SSID 0.710 0.648 −0.560 1.980 0.27
UK × DLAB −0.175 0.577 −1.305 0.955 0.76
UK × DSTO 0.418 1.419 −2.363 3.199 0.77
UK × MCAV 0.323 0.463 −0.585 1.232 0.49
UK × OANN −1.134 1.116 −3.321 1.052 0.31
UK × OFAV −0.730 0.320 −1.357 −0.102 0.02
UK × PSTR 0.083 0.767 −1.420 1.587 0.91
UK × SSID −0.795 0.504 −1.783 0.194 0.12
Random effects
Intercept (Coral ID) 1.024
Parameter estimates, standard errors (SE), and lower and upper 95% confidence limits (LCL and UCL) are from the best-approximating mixed effects logistic regression
model. All estimates are on the log-odds scale, and random effects are reported as standard deviations. The default parameters for comparison were: Days – 0, Habitat –
Inshore, Region – lower Keys, and Species – C. natans (CNAT).
2. Presence of more biodiverse and intact coral communities
at inshore reefs confers resilience. The inshore reefs
of the Florida Keys, including those treated here, have
higher coral cover, larger average colony size, more
evenly distributed population structures, greater species
diversity, and higher coral growth rates than their offshore
counterparts (Lirman and Fong, 2007; Ruzicka et al.,
2013; Manzello et al., 2015; Vega-Rodriguez et al., 2015).
Such biodiversity may have an impact on community
disease susceptibility [see review in Rohr et al. (2020)].
Arguments for high biodiversity helping to protect
individuals within an ecosystem include higher densities of
non-susceptible hosts, lower numbers of susceptible hosts,
and potential consumption of pathogens. In contrast,
for a disease such as SCTLD which affects a large
number of species, increased diversity and coral density
may instead provide more hosts and worsen disease.
Epidemiological models of SCTLD have indicated that
more diverse sites may have higher SCTLD prevalence
(Muller et al., 2020), while prevalence is independent of
colony density (Sharp et al., 2020). Devastating SCTLD
impacts on other regions with more intact reefs further
suggest that this hypothesis of diverse and intact reef
communities reducing SCTLD impact or improving
treatment success is incorrect, but this may warrant
future research.
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FIGURE 6 | Mean predicted probability (solid lines) of corals exhibiting no active disease (NAD) for eight species across two geographic variables: inshore/offshore
and upper/middle/lower Keys (UK/MK/LK). Shaded areas represent 95% confidence intervals. Model predictions represent corals initially treated with amoxicillin and
retreated as necessary during subsequent monitoring events.
3. Presence of more resistant and resilient coral colonies
at inshore reefs results in lower reinfection rates.
Historic losses of non-Acroporid corals on offshore reefs
are generally attributed to early (1989–1998) bleaching
events (Somerfield et al., 2008), which did not cause
the same levels of mortality on inshore reefs. One
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TABLE 6 | Tukey-adjusted pairwise comparisons (p-values) of “no active disease”
(NAD) rates between inshore and offshore sites for eight coral species using the
best approximating model.
Species estimate SE df t. ratio p.value
CNAT 1.423 0.286 8920 4.981 <0.0001
DLAB 1.355 0.457 8920 2.965 0.003
DSTO 1.953 1.106 8920 1.766 0.078
MCAV 0.627 0.232 8920 2.698 0.007
OANN 1.442 0.894 8920 1.612 0.107
OFAV 1.788 0.195 8920 9.19 <0.0001
PSTR 1.603 0.462 8920 3.473 0.001
SSID 2.255 0.439 8920 5.137 <0.0001
For six species (Colpophyllia natans, Diploria labyrinthiformis, Montastraea
cavernosa, Orbicella faveolata, Pseudodiploria strigosa, and Siderastrea siderea)
amoxicillin-treated corals at inshore sites were more likely to be NAD than those
at offshore sites.
hypothesis is that these inshore corals are stress-hardened
as a result of higher temperature fluctuations, higher
turbidity, and generally poorer water quality (Lirman
and Fong, 2007), making individual colonies more
resilient to bleaching-related mortality and perhaps
to disease. Such resilience could present within the
SCTLD treatment regime as an enhanced ability to
resist reinfection events and/or to fight off a systemic
infection with the help of treatment more effectively than
offshore corals.
4. Isolation of inshore reefs may reduce reinfection potential.
The reef tract off the Florida Keys consists of a largely
continuous forereef punctuated by high-relief spur and
groove formations. Though not densely populated with
corals, this forereef presents a relatively continuous
habitat for susceptible species that may act as continual
reservoirs of SCTLD, capable of continually causing
forereef reinfections even if pathogens are managed
locally. In contrast, inshore sites are localized patch reefs
separated from other coral habitat by sand or seagrass
(Figure 7). Given sufficient time and the dynamic water
movements of the region, all sites are likely to receive
pathogen loads that result in infections. Those initial
infections are likely to result in localized community
spread within sites (Williams et al., 2021). During our
initial treatment periods, more diseased colonies per unit
area were present on inshore reefs than on offshore
reefs. This would have suggested a higher localized
pathogen load which would be expected to result in
higher rates of reinfection at inshore reefs; however,
the opposite pattern was observed. We suggest that
localized intervention efforts were effective at reducing
or even eliminating community spread within reefs,
and that any subsequent reinfections on treated reefs
resulted from transmission from surrounding untreated
areas. On average, 6.5% (±3.2 SD) of the habitat within
4 km of the offshore treatment sites was coral reef.
In contrast, only 0.7% (±0.2 SD) of the habitat within
4 km of the inshore treatment sites consisted of reef.
We speculate that while both offshore and inshore
reefs benefited from reduction of local pathogen loads
as a result of treatment, the lower reinfection rates
of inshore reefs were the result of their isolation and
hence their decreased probability of reinfection from
surrounding areas.
These hypotheses, or any combination of them, may render
corals on inshore reefs less susceptible to reinfection and/or
more responsive to treatment. Experimentation would be
necessary to identify the relevant variables, and such research
is recommended as it carries consequential management and
biological implications. However, even without knowing the
causal factors, we have identified that high-diversity, high-cover,
isolated reefs that are susceptible to regular bleaching respond
better to amoxicillin treatment than low-cover reefs surrounded
by reef habitat that do not bleach. In the Florida Keys, these
reefs further represent the highest potential for reproductive
capacity based on proximity of conspecifics and abundance
of SCTLD-susceptible species. Further, colony density at these
sites results in much higher treatment and monitoring efficacy
TABLE 7 | Tukey-adjusted pairwise comparisons (p-values) of “no active disease” (NAD) rates among amoxicillin-treated colonies of eight coral species by region.






OFAV O–MK (0.005) O-LK (0.014) I-UK (0.031) I-UK (0.050)
O–UK (0.024)
I–UK (0.005)
SSID O-LK (0.019) O-LK (0.014)
O-UK (0.001)
Regions are Offshore (O-) and Inshore (I-) as well as upper Keys (UK), middle Keys (MK), and lower Keys (LK). Orbicella faveolata had lower probability of being NAD than
six other species/habitat combinations. Siderastrea siderea had a lower probability than three other species/habitat combinations. And Colpophyllia natans had a lower
probability than one other species/habitat combination.
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FIGURE 7 | Habitat maps surrounding six treatment sites (inshore and offshore within each region) indicating the relative isolation of inshore sites from surrounding
reef environments compared to offshore sites. Red indicates reef environment, and black circles indicate treatment sites. All maps are to the same scale. Percentage
values in each map indicate the percentage of habitat within a 4 km radius of each site that is reef habitat. Habitat classifications are derived from the Florida Unified
Reef Map.
FIGURE 8 | Monthly survivorship curves for five coral species within the amoxicillin treatment regime (solid lines) and chlorinated epoxy treatment regime (dashed
lines). Mortality of chlorinated epoxy-treated brain corals (Colpophyllia natans, Pseudodiploria strigosa, and Diploria labyrinthiformis) was rapid until all treatments
were switched to amoxicillin 3 to 5 months after initial treatments. Species-specific mortality rates of corals at reported time points from other studies are indicated
with shapes. Note that most other studies follow all corals within the population (including those which do not develop SCTLD), while the amoxicillin and chlorinated
epoxy mortality curves follow only corals that were treated for SCTLD.
Frontiers in Marine Science | www.frontiersin.org 14 August 2021 | Volume 8 | Article 675349
fmars-08-675349 July 27, 2021 Time: 12:43 # 15
Neely et al. Comparing Coral Disease Treatments
compared to offshore sites that require considerable search time
to find remaining live colonies. We recommend that intervention
resources be focused primarily on these areas of high coral cover,
high species diversity, better response to treatment, and high
work efficiency.
Two years after initial treatments, mortality of SCTLD-
affected colonies treated under the amoxicillin regims was only
5%. One limitation of this study is the lack of non-treated
controls; the decision to treat all SCTLD-affected corals was
based on observations and studies throughout Florida and now
through the Caribbean identifying extremely high mortality rates.
Comparisons with non-treated corals monitored through these
other studies highlight the value of such work (Figure 8).
1. Neely et al. (2020) tested controls and placebo treatments
alongside amoxicillin treatments in the Florida Keys
and identified control/placebo 1-month mortality rates of
60% on D. labyrinthiformis, 25% on C. natans, 50% on
P. strigosa, 17% on M. cavernosa, and 0% on O. faveolata.
2. In work by Precht et al. (2016) on tagged SCTLD-affected
colonies in Southeast Florida, mortality of SCTLD-afflicted
colonies after 9 months was 100% across four species
(9 Meandrina meandrites, 10 D. stokesii, 1 C. natans,
4 P. strigosa, 8 M. cavernosa, 1 P. clivosa, and 2
Solenastrea. bournoni).
3. Thome et al. (2021) tagged 96 P. strigosa colonies on an
SCTLD-affected reef in Mexico; within 306 days, mortality
was greater than 84%, with nearly half of the surviving
colonies actively diseased at that point.
4. Aeby et al. (2019) tagged 13 actively diseased colonies in
the Florida Keys (5 P. strigosa, 5 D. labyrinthiformis, 2
D. stokesii, and 1 Meandrina jacksonii); within 7 months,
100% of these were dead.
5. Williams et al. (2021) followed colonies at offshore and mid-
channel Florida Keys reefs through 14 months after SCTLD
onset, and nearshore colonies through 10 months after
SCTLD onset; mortality rates were 50–71% on D. stokesii,
33–83% on D. labyrinthiformis, 1–20% on M. cavernosa, 0–
25% on O. faveolata, 25–77% on C. natans, and 27–75% on
P. strigosa.
6. Though not tracking individual colonies, Walton et al.
(2018) documented declines in density of 90% in
D. stokesii, 95% in M. meandrites, 50% in M. cavernosa, and
32% in S. siderea over 2 years through the SCTLD outbreak.
7. Fixed survey sites in the upper Florida Keys documented
substantial losses in colonies between pre-SCTLD years
(average of 2014 – 2016) and post-SCTLD (2018): 18% of
Orbicella colonies, 52% of M. cavernosa, 78% of P. strigosa,
84% of D. stokesii, 91% of D. labyrinthiformis, and 100% of
C. natans and M. meandrites (CREMP, unpublished data).
These known rates of exceptionally high mortality as a
result of SCTLD infection highlight the importance of in-water
treatment if in situ colonies are to be saved. These colonies
represent centuries of growth highlighting a track record of
hardiness against stressors. The habitat, reproductive output, and
ecosystem services they provide are essential for reefs, even those
undergoing restoration efforts. The effectiveness of amoxicillin
treatments in halting SCTLD lesions and the long-term reduction
in diseased colonies at sites that are regularly monitored and
treated as needed identifies the use of this in-water intervention
on SCTLD-affected sites as a viable method for saving corals and
coral diversity in the presence of this unprecedented disease.
CONCLUSION
Corals affected by SCTLD were treated using two experimental
methods to halt disease lesions: chlorinated epoxy and an
amoxicillin paste. Logistic regression models from post-
treatment monitoring data identified amoxicillin treatments
as effective across all species; in contrast, chlorinated epoxy
treatments failed across all species, with failure rates more
rapid on species with faster lesion progression rates. Corals that
were initially treated and then revisited approximately every
2 months for treatments on new lesions as needed showed
long-term improvements in health, with nearly 95% of treated
corals exhibiting no signs of disease after 2 years. Species-
specific comparisons in long-term health identified some species
(particularly O. faveolata) as more susceptible to reinfections
than others. Geographic comparisons showed that treated corals
on inshore reefs had better long-term prognoses than those on
offshore reefs. Hypotheses as to why inshore reefs respond better
include: summer inshore bleaching events may reduce pathogen
load, isolation from other reefs may limit reinfections, and
stress-hardening or benefits of biodiversity may enhance colony
resilience. The short- and long-term effectiveness of amoxicillin
treatments provides an effective tool for preventing mortality of
corals affected by SCTLD.
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